Anlon Healthcare
Anlon Healthcare (AHCL) share price was ₹24.47 at the 28 Oct 2026 close; market capitalisation ₹1,301 Cr; sector Healthcare. The share price rose 97.3% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 162.9% year on year to ₹87.56 Cr and net profit rose 133.2% year on year to ₹8.28 Cr (compared with Jun 2025). Promoters held 52.68% of Anlon Healthcare in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 42/100 (Weak) as of 28 Oct 2026.
Key Fundamentals
MicrocapPharmaceuticals & BiotechnologyHealthcarePrice-based figures as of 29 Oct 2026, 11:11 IST · TTM
Peer Comparison
Healthcare › Pharmaceuticals
| ₹1,767.00 | 35.05 | 4,23,962 Cr | 5.07 | 0.91% | 13.79% | 17.94% | 61,848 Cr | 12,117 Cr | |
| ₹9,639.50 | 87.49 | 2,55,898 Cr | 15.27 | 0.32% | 15.32% | 18.96% | 11,682 Cr | 2,925 Cr | |
| ₹4,595.60 | 72.14 | 1,74,802 Cr | 9.51 | 0.82% | 12.16% | 9.06% | 17,058 Cr | 2,156 Cr | |
| ₹2,185.70 | 107.99 | 1,18,096 Cr | 22.28 | 0.09% | 16.38% | 19.67% | 7,323 Cr | 1,090 Cr | |
| ₹1,180.60 | 26.27 | 1,17,765 Cr | 4.34 | 0.09% | 16.99% | 19.24% | 28,515 Cr | 4,593 Cr | |
| ₹1,340.50 | 34.72 | 1,11,889 Cr | 2.88 | 0.61% | 10.87% | 13.94% | 34,247 Cr | 3,184 Cr | |
| ₹1,370.10 | 32.82 | 1,10,685 Cr | 3.13 | 0.96% | 11.21% | 14.88% | 28,589 Cr | 3,356 Cr | |
| Anlon Healthcare (this company) | ₹24.25 | — | 1,289 Cr | 5.60 | 0.00% | 11.42% | 17.36% | 227 Cr | 34 Cr |
| Median 8 companies | ₹1,568.55 | 35.05 | 1,17,931 Cr | 5.34 | 0.47% | 12.98% | 17.65% | 22,787 Cr | 3,055 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 95/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company has reduced debt.
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 220 days.
Technical Indicators
Oscillators
Bullish
Overall
Bullish
Moving Averages
Bullish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 17.8% · Jun 2026
Quarterly Results
| Particulars | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Sales | 48.93 | 33.3 | 35.58 | 50.89 | 87.56 |
| Expenses | 31.74 | 27.06 | 23.3 | 35.6 | 71.97 |
| Operating Profit | 17.19 | 6.24 | 12.28 | 15.29 | 15.59 |
| OPM % | 35.13% | 18.74% | 34.51% | 30.05% | 17.8% |
| Other Income | 0.04 | 0.01 | 0.2 | 0.01 | 0.06 |
| Interest | 0.91 | 0.82 | 1.51 | 0.57 | 0.92 |
| Depreciation | 0.83 | 0.43 | 0.35 | 0.29 | 1.07 |
| PBT | 15.49 | 5 | 10.62 | 14.44 | 13.66 |
| Tax % | -7.49% | 29.2% | 51.41% | 23.34% | 39.39% |
| Net Profit | 16.65 | 3.55 | 5.15 | 11.07 | 8.28 |
| EPS (₹) | 0.42 | 0.09 | 0.1 | 0.2 | 0.13 |
Profit & Loss
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Sales | 120 | 172 |
| Expenses | 88 | 124 |
| Operating Profit | 32 | 48 |
| OPM % | 27% | 28% |
| Other Income | 0 | 0 |
| Interest | 4 | 4 |
| Depreciation | 2 | 2 |
| PBT | 27 | 43 |
| Tax % | 24% | 32% |
| Net Profit | 21 | 29 |
| EPS (₹) | 0.51 | 0.54 |
| Div. Payout % | 0% | 0% |
Balance Sheet
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity Capital | 40 | 53 |
| Reserves | 41 | 177 |
| Borrowings | 67 | 44 |
| Other Liabilities | 34 | 100 |
| Total Liabilities | 181 | 374 |
| Fixed Assets | 23 | 58 |
| CWIP | 0 | 0 |
| Investments | 1 | 1 |
| Other Assets | 158 | 315 |
| Total Assets | 181 | 374 |
Cash Flow
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Operating | -22 | -59 |
| Investing | 2 | -36 |
| Financing | 19 | 118 |
| Net Cash Flow | -1 | 23 |
| Free Cash Flow | -19 | -95 |
| CFO/EBITDA | -85 | -114 |
Ratios
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Debtor Days | 228 | 220 |
| Inventory Days | 246 | 393 |
| Days Payable | 96 | 147 |
| Cash Conversion Cycle | 377 | 467 |
| Working Capital Days | 292 | 417 |
| ROCE % | — | 21% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Anlon Healthcare insights
65 extracted metrics + investor summaries across FY17–FY27.
Documents
Frequently Asked Questions about Anlon Healthcare
What does Anlon Healthcare Ltd do?
Where is Anlon Healthcare Ltd (AHCL) listed?
Which sector does Anlon Healthcare Ltd belong to?
What is the market capitalisation of Anlon Healthcare Ltd?
What is the 52-week high and low of Anlon Healthcare Ltd?
What is the Return on Equity (ROE) of Anlon Healthcare Ltd?
Company Information
Incorporated in 2013, Anlon Healthcare Limited is a chemical manufacturing company engaged in the manufacturing of Pharma Intermediates and active pharmaceutical ingredients (APIs).[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/AHCL.md for Anlon Healthcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.